When evaluating a patient who is taking orlistat, which is an intended therapeutic effect?
Decreased weight
Increased appetite
Decreased hyperactivity
Increased wakefulness
The Correct Answer is A
A. Decreased weight: Orlistat is a medication used for weight management by inhibiting the absorption of dietary fats. Its intended therapeutic effect is to promote weight loss by reducing the amount of fat absorbed from the diet.
B. Increased appetite: Orlistat does not increase appetite; rather, it may help control appetite by promoting satiety through its mechanism of action.
C. Decreased hyperactivity: Orlistat is not indicated for the treatment of hyperactivity.
D. Increased wakefulness: Orlistat does not affect wakefulness; it primarily acts in the gastrointestinal tract to inhibit fat absorption.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. The 21-year-old patient who has never had surgery before: While lack of previous surgery experience may contribute to anxiety, it doesn't inherently increase the risk of altered response to anesthesia.
B. The 40-year-old patient who is to have kidney stone removed: While the type of surgery may influence anesthesia considerations, being 40 years old alone doesn't significantly increase the risk of altered response to anesthesia.
C. The 82-year-old patient who is to have gallbladder removal: Advanced age is a significant risk factor for altered response to anesthesia due to age-related changes in physiology, metabolism, and drug clearance.
D. The 35-year-old patient who stopped smoking 8 years ago: While smoking history can impact anesthesia considerations, stopping smoking 8 years ago likely reduces the associated risks compared to current smokers.
Correct Answer is A
Explanation
A. Improved ability to perform activities of daily living: Antiparkinson medications are aimed at improving motor symptoms such as tremors, rigidity, and bradykinesia, leading to improved function in activities of daily living.
B. Decreased appetite: Decreased appetite is not a therapeutic response to antiparkinson medications. In fact, some medications may cause weight gain due to increased appetite.
C. Newly developed dyskinesias: Dyskinesias are involuntary movements that can occur as a side effect of long-term treatment with antiparkinson medications, particularly levodopa. They are not a therapeutic response and may require adjustments to medication.
D. Gradual development of cogwheel rigidity: Cogwheel rigidity is a symptom of Parkinson's disease and would not be expected to develop gradually with treatment. Antiparkinson
medications aim to reduce rigidity, not cause it.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.